Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Acamprosate Calcium Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Acamprosate Calcium Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 333 mg Delayed Release Tablet
      • 1.3.3 Type II
    • 1.4 Market Segment by Application
      • 1.4.1 Global Acamprosate Calcium Market Share by Application (2019-2025)
      • 1.4.2 Hospital
      • 1.4.3 Drug store
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Acamprosate Calcium Market Size
      • 2.1.1 Global Acamprosate Calcium Revenue 2014-2025
      • 2.1.2 Global Acamprosate Calcium Sales 2014-2025
    • 2.2 Acamprosate Calcium Growth Rate by Regions
      • 2.2.1 Global Acamprosate Calcium Sales by Regions 2014-2019
      • 2.2.2 Global Acamprosate Calcium Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Acamprosate Calcium Sales by Manufacturers
      • 3.1.1 Acamprosate Calcium Sales by Manufacturers 2014-2019
      • 3.1.2 Acamprosate Calcium Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Acamprosate Calcium Revenue by Manufacturers (2014-2019)
      • 3.2.2 Acamprosate Calcium Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Acamprosate Calcium Market Concentration Ratio (CR5 and HHI)
    • 3.3 Acamprosate Calcium Price by Manufacturers
    • 3.4 Key Manufacturers Acamprosate Calcium Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Acamprosate Calcium Market
    • 3.6 Key Manufacturers Acamprosate Calcium Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 333 mg Delayed Release Tablet Sales and Revenue (2014-2019)
      • 4.1.2 Type II Sales and Revenue (2014-2019)
    • 4.2 Global Acamprosate Calcium Sales Market Share by Type
    • 4.3 Global Acamprosate Calcium Revenue Market Share by Type
    • 4.4 Acamprosate Calcium Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Acamprosate Calcium Sales by Application

    6 United States

    • 6.1 United States Acamprosate Calcium Breakdown Data by Company
    • 6.2 United States Acamprosate Calcium Breakdown Data by Type
    • 6.3 United States Acamprosate Calcium Breakdown Data by Application

    7 European Union

    • 7.1 European Union Acamprosate Calcium Breakdown Data by Company
    • 7.2 European Union Acamprosate Calcium Breakdown Data by Type
    • 7.3 European Union Acamprosate Calcium Breakdown Data by Application

    8 China

    • 8.1 China Acamprosate Calcium Breakdown Data by Company
    • 8.2 China Acamprosate Calcium Breakdown Data by Type
    • 8.3 China Acamprosate Calcium Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Acamprosate Calcium Breakdown Data by Company
    • 9.2 Rest of World Acamprosate Calcium Breakdown Data by Type
    • 9.3 Rest of World Acamprosate Calcium Breakdown Data by Application
    • 9.4 Rest of World Acamprosate Calcium Breakdown Data by Countries
      • 9.4.1 Rest of World Acamprosate Calcium Sales by Countries
      • 9.4.2 Rest of World Acamprosate Calcium Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Merck Group
      • 10.1.1 Merck Group Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Acamprosate Calcium
      • 10.1.4 Acamprosate Calcium Product Introduction
      • 10.1.5 Merck Group Recent Development
    • 10.2 Zydus Pharmaceuticals
      • 10.2.1 Zydus Pharmaceuticals Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Acamprosate Calcium
      • 10.2.4 Acamprosate Calcium Product Introduction
      • 10.2.5 Zydus Pharmaceuticals Recent Development
    • 10.3 Mylan
      • 10.3.1 Mylan Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Acamprosate Calcium
      • 10.3.4 Acamprosate Calcium Product Introduction
      • 10.3.5 Mylan Recent Development
    • 10.4 Teva
      • 10.4.1 Teva Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Acamprosate Calcium
      • 10.4.4 Acamprosate Calcium Product Introduction
      • 10.4.5 Teva Recent Development
    • 10.5 Glenmark Pharmaceuticals
      • 10.5.1 Glenmark Pharmaceuticals Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Acamprosate Calcium
      • 10.5.4 Acamprosate Calcium Product Introduction
      • 10.5.5 Glenmark Pharmaceuticals Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Acamprosate Calcium Sales Channels
      • 11.2.2 Acamprosate Calcium Distributors
    • 11.3 Acamprosate Calcium Customers

    12 Market Forecast

    • 12.1 Global Acamprosate Calcium Sales and Revenue Forecast 2019-2025
    • 12.2 Global Acamprosate Calcium Sales Forecast by Type
    • 12.3 Global Acamprosate Calcium Sales Forecast by Application
    • 12.4 Acamprosate Calcium Forecast by Regions
      • 12.4.1 Global Acamprosate Calcium Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Acamprosate Calcium Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Acamprosate calcium delayed-release tablets are indicated for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation. Treatment with acamprosate calcium delayed-release tablets should be part of a comprehensive management program that includes psychosocial support.
      In 2019, the market size of Acamprosate Calcium is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Acamprosate Calcium.

      This report studies the global market size of Acamprosate Calcium, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Acamprosate Calcium sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Merck Group
      Zydus Pharmaceuticals
      Mylan
      Teva
      Glenmark Pharmaceuticals
      ...

      Market Segment by Product Type
      333 mg Delayed Release Tablet
      Type II

      Market Segment by Application
      Hospital
      Drug store

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Acamprosate Calcium status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Acamprosate Calcium manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Acamprosate Calcium are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now